Jasper Ridge Partners L.P. Acquires Shares of 18,134 Tempus AI, Inc. $TEM

Jasper Ridge Partners L.P. acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEMFree Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 18,134 shares of the company’s stock, valued at approximately $875,000.

Other large investors have also recently made changes to their positions in the company. Wells Fargo & Company MN boosted its stake in Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after buying an additional 278 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Tempus AI by 157.7% during the 4th quarter. Envestnet Asset Management Inc. now owns 44,119 shares of the company’s stock worth $1,489,000 after acquiring an additional 26,998 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Tempus AI during the 4th quarter worth approximately $3,757,000. NewEdge Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter valued at approximately $49,000. Finally, Stifel Financial Corp grew its holdings in shares of Tempus AI by 935.1% in the fourth quarter. Stifel Financial Corp now owns 39,810 shares of the company’s stock valued at $1,344,000 after purchasing an additional 35,964 shares in the last quarter. 24.22% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on TEM. Bank of America upped their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. Morgan Stanley boosted their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Needham & Company LLC restated a “buy” rating and set a $70.00 target price on shares of Tempus AI in a research report on Friday, August 8th. BTIG Research lifted their price target on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Guggenheim boosted their price objective on Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $67.64.

Check Out Our Latest Stock Analysis on Tempus AI

Insider Activity at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the completion of the sale, the chief executive officer directly owned 9,357,283 shares in the company, valued at approximately $655,664,819.81. This trade represents a 2.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erik Phelps sold 51,317 shares of the business’s stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the sale, the executive vice president directly owned 97,779 shares of the company’s stock, valued at $7,094,844.24. This represents a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 776,451 shares of company stock worth $53,022,688 over the last quarter. 27.60% of the stock is owned by insiders.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $80.52 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45. The company has a market capitalization of $13.99 billion, a price-to-earnings ratio of -67.66 and a beta of 4.98. The firm’s 50-day moving average is $63.78 and its 200 day moving average is $59.21.

Tempus AI (NASDAQ:TEMGet Free Report) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company’s revenue for the quarter was up 89.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

About Tempus AI

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEMFree Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.